Fixed-Duration Epcoritamab Plus Chemotherapy Yields Response, Remissions in DLBCL
Updated results highlight the promise of epcoritamab combined with chemotherapy for newly diagnosed DLBCL.
Emerging Data Suggest Select Benefit for Venetoclax in MDS: Ivo Carre, PhD
Ivo Carre, PhD, shares subgroup data that points to potential benefit in younger patients with high-risk MDS.
Evaluating A-HIPI vs Traditional Scores in Advanced Hodgkin Lymphoma: Andrew Evens, DO, MBA, MSc
Andrew Evens, DO, MBA, MSc, shares insights from a study on improving prognostic accuracy for advanced-stage Hodgkin lymphoma.
Targeted Therapies, Key Subgroup Insights to Watch at ASH 2025
New data in high-risk MDS, emerging menin inhibitors in AML, and evolving care needs in rare bleeding disorders set the stage for major ASH 2025 discussions.
Innovative Approaches in Academic Neurology Workflows
Experts at an Institute for Value-Based Medicine event held October 14, 2025, in Aurora, Colorado, explored advances in neurology care, cross-specialty collaboration, and strategies to improve access and therapy.
Lumateperone Improves Depression in Patients With Inadequate Antidepressant Response
A phase 3 trial shows lumateperone added to antidepressant therapy delivers greater symptom improvement and maintains a favorable safety profile in adults with MDD.
Angiogenesis Inhibitors Not Linked to Arterial Dissections, Aneurysms in Colorectal Cancer
A study finds no increased risk of arterial dissections or aneurysms among patients with metastatic colorectal cancer treated with angiogenesis inhibitors.
Political Ideology Impacts Trust in Scientists for Cancer Information
A national survey shows high overall trust in scientists, but confidence declines steadily with political conservatism.
Low WIC Food Redemption Linked to Higher Risk of Program Dropout
Children with lower redemption of key WIC foods are more likely to discontinue participation before age 3, study finds.
FDA Grants Full Approval to Pirtobrutinib for CLL/SLL
Pirtobrutinib is now fully approved for CLL/SLL in those previously treated with Bruton tyrosine kinase inhibitors.
Long-Term Adalimumab Improves Work, Life Quality in Psoriasis
Adalimumab significantly reduces activity limitations and boosts work ability and quality of life in patients with psoriasis.
Colorectal Cancer Screening in Younger Adults Increases After Guideline Changes
Screening among 45- to 49-year-olds rose nearly 10-fold in hospitals after US guideline updates, but disparities persist.
5 Ways ACOs Can Improve Care, Achieve Meaningful Savings
Shared savings reflects continued growth of long-term-care ACOs in Medicare’s value-based models.
Telemental Health Now Serves 1 in 4 Outpatients
Telehealth has quickly become a central part of the mental health system among younger, higher-income, college-educated, and privately insured patients.
Which Factors Most Affect Quality of Life in Colorectal Cancer?
A study identifies tumor stage and stoma status as key drivers of diminished quality of life among patients with colorectal cancer.
Antibiotics May Reduce Biologic Therapy Persistence in Psoriasis
Exposure to antibiotics is linked to higher risk of biologic discontinuation in psoriasis, potentially through gut microbiota changes.
Emerging Breakthroughs in Neurodegenerative Disease Treatments: Kavita Nair, PhD, FAAN
Kavita Nair, PhD, FAAN, shares how new therapies and ongoing clinical trials are reshaping the future of neurological care and offering new hope to patients.
Urticaria Symptoms, Sleep Improve With Remibrutinib: Mark Lebwohl, MD
Urticaria symptom reduction with remibrutinib was linked with improved quality of life and sleep for patients with chronic spontaneous urticaria.
Quick Responses May Boost Adherence to Remibrutinib in CSU: Michael J. Palumbo, MD
Remibrutinib shows rapid and sustained relief for chronic spontaneous urticaria, offering a promising oral treatment option for patients.
Addressing Uptake, Adherence, and Attrition in Mental Health Apps
Randomized clinical trials increasingly support mental health apps as scalable, cost-efficient tools for managing depression and anxiety.
How Academic Medical Centers Address Neurological Care: Kavita Nair, PhD, FAAN
Kavita Nair, PhD, FAAN, discusses academic medical centers' unique role in diagnosing and managing neurodegenerative diseases.
Ultraprocessed Foods Linked to Higher Risk of Early-Onset Colorectal Adenomas
Women under 50 who consume high levels of ultraprocessed foods have a higher risk of developing early-onset conventional colorectal adenomas.
Guselkumab Shows Sustained 48-Week Protection Against Joint Damage in PsA
Guselkumab significantly inhibited structural joint damage and improved symptoms in active PsA through 48 weeks.
How Trump’s Trade Policy Could Raise Costs, Deepen Drug Shortages
Experts say proposed pharmaceutical tariffs could raise drug prices, impacting patient access and health care budgets.
NIH F32 Grants Boost Early-Career Researchers’ Success
One-third of F32 grant recipients secure follow-up NIH K awards, fueling new biomedical discoveries and career growth.
Project Cure CRC Awards New Grants to Advance Colorectal Cancer Care
The Colorectal Cancer Alliance expands its $100 million Project Cure CRC with 3 new grants driving innovation and improving patient outcomes.
Total Neoadjuvant Therapy May Aid Organ Preservation in Early Rectal Cancer
Total neoadjuvant treatment achieved high complete response and organ preservation rates in patients with stage I rectal cancer, according to a new study.
Stronger Carer-Child Bonds Don’t Predict Later Mental Health
Foster and kinship care children formed stronger bonds with carers, but relationship quality didn’t predict later emotional outcomes, a study finds.
Identifying Psychological Burdens in Non–Plaque Psoriasis
New findings reveal high rates of depression, anxiety, and sleep issues in individuals with psoriatic arthritis and palmoplantar psoriasis.
High Fiber Linked to Fewer Bowel Symptoms in CRC Survivors
Higher dietary fiber intake was associated with a reduced risk of moderate to severe diarrhea up to 2 years after diagnosis.
